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Abstract:A significant sensitization to the ambulation-stimulating effect of morphine (10 mg/kg s.c.), a narcotic analgesic 
drug with agonistic action on opiate receptors, was produced when mice were repeatedly administered morphine at 
intervals of 3 days, and their ambulation was measured for 3 hr in an activity cage of 20 cm in diameter after each 
administration.  Naloxone (0.01-1 mg/kg s.c.), an opiate receptor antagonist, blocked the morphine-induced ambulation 
in a dose-dependent manner.  The mice treated with naloxone at post-morphine period of 3/4 hr and later showed a strong 
ambulatory sensitization as high as that in the mice repeatedly given morphine alone.  The treatment with naloxone at 
post-morphine period of 1/2 hr caused a partial sensitization, and at 0-1/3 hr no significant sensitization.  The repeated 
administrations of naloxone alone or saline caused no significant change in the sensitivity to morphine.  These results 
suggest that experience of morphine effect and the resultant ambulation for 1/2 hr prior to the peak effect is important for 
induction of the sensitization to the ambulation-increasing effect of morphine in mice.  This finding also indicates that the 
reward effect of morphine appears in the early post-morphine period prior to the peak effect, which is the essential factor 
for induction and maintenance of the abuse and dependence of narcotic analgesic drugs such as morphine and heroin.
(Reprint request should be sent to Hisashi Kuribara)
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Introduction
Morphine, a prototype of narcotic analgesic drug, facili-
tates the dopamine release through an agonistic action on 
opiate receptors in the brain (Buxbaum, 1973; Joyce and 
Iversen, 1979; Teitelbaum et al., 1979).  Mesolimbic dopa-
minergic systems (Van der Heuval and Pasterkamp, 2008) 
play significant roles in the behavioral and psychological 
activities, particularly motivation (Matsumoto and Hikosa-
ka, 2009), learning and memory (Arias-Carrion and Pop-
pel, 2007; Ikemoto, 2007), and substance abuse (Piercem 
and Kumaresan 2006; Berridge, 2007; Ikemoto, 2007).
In the drug abuse and dependence, which are intimately 
related to the stimulant effect on the mesolimbic dopami-
nergic systems in the brain (Valdman, 1986), the drugs 
having dependence liability are repeatedly administered, 
indicating the importance to study the change in the drug 
effects following repeated administrations.
The behavioral study in terms of ambulatory activity in 
mice demonstrated that the repeated administrations of 
morphine at intervals of shorter than 12 hr resulted in tol-
erance (Kuribara, 1996c), whereas significant sensitization 
at intervals of 12 hr and longer (Kuribara and Tadokoro, 
1989; Kuribara, 1996c).  It has been considered that 
changes in the opiate and/or dopaminergic neurotransmis-
sion are involved in the induction of behavioral sensitiza-
tion to morphine because of the inhibitory action of nalox-
one, an opiate receptor antagonist, or the dopamine D-2 
receptor antagonist, nemonapride (Kuribara, 1995a). 
Furthermore, it has been demonstrated that, to induce 
the sensitization to the ambulatory stimulant effect of 
methamphetamine (Kuribara, 1995b, 1996a,b) and cocaine 
(Kuribara, 1996a,2009), a free ambulation for 1/2 hr and 
1/4 hr, respectively, during the post-drug period of 0-1 hr 
is important.
The aim of this study was to assess the time-dependent 
modification by naloxone of sensitization to the ambulato-
ry stimulant effect of morphine in mice.




Male mice of ddY strain (SLC Japan, Hamamatsu) were 
used at 6 weeks of age and a weight of 25-28 g.  Groups of 
10 mice each had been housed in Polycarbonate cages 
(20W × 25L × 15H cm), and they were given a solid diet 
(MF: Oriental Yeast, Tokyo) and tap water except during 
the behavioral tests.  The conditions of the breeding room 
were controlled (temperature; 23 ± 1℃ , relative humidi-
ty; 55 ± 3%, and a 14:10-hr light-dark cycle; lights on be-
tween 05:00-19:00 hr). 
Apparatus
The ambulatory activities of 10 mice were individually 
and simultaneously measured with a tilting-type ambu-
lometer which had 10 bucket-like Plexiglas activity cages 
of 20 cm in diameter and 15 cm in height (SMA-10: O’
hara & Co., Tokyo).  The apparatus selectively detected 
horizontal, but not vertical, movements (ambulation) of the 
mouse.
Drugs
The drugs used were morphine HCl (Takeda Chemicals, 
Osaka) and naloxone (Sigma, Chicago, IL).  Morphine and 
naloxone were dissolved in physiological saline, and sub-
cutaneously (s.c.) administered at a constant volume of 0.1 
ml/10 g body weight of the mouse.
Experimental schedules
All the experimental treatments, i.e., the administration of 
morphine and naloxone, and measurement of ambulation of 
the mouse, were carried out between 09:00-16:00 hr.
All drug administrations to the mice were conducted af-
ter a habituation period for 10 min to the activity cage.
Experiment 1. Single administration of morphine, and co-
administration of morphine with naloxone
Four groups of 10 mice each were administered saline, 
or morphine (2.5, 5, 10 or 20 mg/kg), and the ambulatory 
activity of each mouse was measured for 3 hr.  Six groups 
of 10 mice each were s.c. co-administered morphine (10 
mg/kg) with naloxone (0: morphine alone, 0.01, 0.03, 0.1, 
0.3 or 1 mg/kg), and the activity of each mouse was mea-
sured for 3 hr.  Other 6 groups of 10 mice each were s.c. 
administered naloxone (0: saline, 0.01, 0.03, 0.1, 0.3 or 1 
mg/kg) alone.
Experiment 2. Evaluation of time course of changes in 
morphine-induced ambulatory stimulation after the repeat-
ed administrations
  Following the results of the previous studies (Iizuka 
and Hirabayashi, 1983; Kuribara and Tadokoro, 1989) and 
Experiment 1, the dose of morphine (10 mg/kg) was con-
sidered to be optimum for induction of sensitization to the 
ambulatory stimulant effect in mice.  Ten mice were re-
peatedly given morphine 6 times at 3-day intervals, and 
they were allowed to freely move in the activity cage for 3 
hr after each administration.  The activity counts were re-
corded every 30 min epoch. 
Experiment 3. Repeated administrations of morphine 
followed by the treatment with naloxone
Following the results of the previous study (Kuribara, 
1995a) and Experiment 1, the dose of naloxone (1 mg/kg) 
was selected to be optimum for complete blockade of mor-
phine-induced ambulatory activity.
Nine groups of mice (10 mice each) were given mor-
phine (10 mg/kg) 3 times at intervals of 3 days, and their 
ambulatory activities were individually measured for 3 hr. 
Furthermore, naloxone (1 mg/kg) was administered at the 
post-morphine period of either 0 (simultaneous administra-
tion), 1/6, 1/3, 3/4, 1/2, 1, 3/2, 2 or 3 hr.  As the control ad-
ministration for morphine, other 9 groups of mice were 
given saline, and followed by administration of naloxone.
Three days after the 3rd treatment, all mice were chal-
lenge-administered morphine (10 mg/kg s.c.) alone.
Ethical condition for experimental animals
All the experimental procedures mentioned above were 
carried out according to the “ Guiding Principles for the 
Care and Use of Laboratory Animals” approved by The 
Japanese Pharmacological Society.
Statistical analysis
The mean activity counts for 3 hr in each group were 
analyzed by analysis of variance (ANOVA).  Post-hoc 
analyses were carried out by Bonferroni test. Values of p 
less than 0.05 were considered significant.
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Results
1.  Single administration of morphine, and co-adminis-
tration of morphine with naloxone (Experiment 1)
As shown in Table 1, morphine dose-dependently accel-
erated the ambulatory activity of mice, and the activity 
counts following 5, 10 and 20 mg/kg were significantly 
higher than the saline control.
The increased morphine-induced ambulatory activity 
was observed for about 3/2 hr after 5 mg/kg, 3 hr after 10 
mg/kg, and longer than 4 hr after 20 mg/kg.
As shown in Table 2, naloxone, at 0.1 mg/kg and higher 
doses, significantly inhibited the morphine (10 mg/kg)-in-
duced ambulatory stimulation, though the administration 
of naloxone alone did not change the activity of mice at 
any doses.
2.  Morphine-induced ambulatory stimulation after the 
repeated administrations (Experiment 2)
Fig. 1 shows the time course of changes in morphine-in-
duced ambulatory stimulation following 6 repeated adminis-
trations at 3-day intervals.  Morphine-induced ambulatory 
Table 1.  Mean activity counts after the s.c. administration of morphine (0: saline, 
2.5, 5, 10 and 20 mg/kg).
Doses of morphine Activity counts Peak effect Duration of activity
0 (saline)  38 ± 9 ND ND
2.5 mg/kg  21 ± 4 ND ND
5  267 ± 23* 1/2-1 hr 2 hr
10  1395 ± 201* 1/2-1 hr 3 hr
20  3738 ± 550* 1-3/2 hr <4 hr
Each activity count is mean ±SEM of 10 mice for 3 hr.  ND: not determined. 
*: significantly different (p<0.05) vs. the activity count after saline administration.
Table 2.  Mean activity counts after the combined s.c. administration 
of morphine (10 mg/kg) and naloxone (0.01-1 mg/kg).
Doses of naloxone Morphine + Naloxone Naloxone alone
0 (saline)  1452 ± 283  32 ± 9
0.01 mg/kg  1194 ± 208  39 ± 10
0.03  706 ± 113*  40 ± 12
0.1  175 ± 41*  36 ± 8
0.3  73 ± 33*  51 ± 6
1.0  47 ± 19*  44 ± 3
Each value is mean activity count±SEM of 10 mice for 3 hr. 
*:  significantly different (p<0.05) vs. the activity count after 
morphine alone (naloxone dose=0).
Fig. 1.  Time course of changes in the ambulatory stimulant 
effect of morphine (10 mg/kg s.c.) after 6 repeated 
administrations at 3-day intervals.  Each point 
represents the mean ambulatory activity count in 
every 30 min epoch.  N=10.
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stimulation attained to the peak during the post-morphine 
period of 1/2-1 hr, and almost disappeared by 3 hr after the 
administration.  The sensitization to the ambulatory stimu-
lant effect was much marked during the post-morphine peri-
od of 1/2-1 hr, and the sensitization attained plateau state by 
the 4th administration.  However, no prolongation of the ef-
fect was demonstrated even after induction of the sensitiza-
tion.
3.  Repeated administrations of morphine followed by 
the treatment with naloxone (Experiment 3)
Table 3 shows the activity counts after 3 repeated ad-
ministrations of morphine followed by naloxone at various 
post-morphine periods.  The repeated administration of 
morphine followed by naloxone at 3/4, 1, 3/2, 2 and 3 hr 
resulted in a significant enhancement of the ambulatory 
stimulation.  However, the treatment with naloxone at post-
morphine period of 1/2 hr caused a partial sensitization, 
and at 0, 1/6 or 1/3 hr no sensitization.
The treatment with saline followed by naloxone neither 
stimulated the ambulatory activity (counts being 43-79), 
nor changed the sensitivity to morphine.
Table 4 shows mean 3-hr activity counts following the 
challenge administration of morphine to the groups of 
mice that had been pretreated with morphine or saline fol-
lowed by naloxone.  The groups of mice pretreated with 3 
repeated administrations of saline followed by naloxone 
did not show significant change in the sensitivity to mor-
phine.
After the challenge administration of morphine, the ac-
tivity counts in the groups of mice pretreated with mor-
phine and naloxone at post-morphine period of 3/4 hr and 
later were as high as that in the group of mice given mor-
phine alone.  Whereas, following the challenge administra-
tion of morphine, the groups of mice pretreated with mor-
phine and naloxone at post-morphine period of 1/2 hr 
showed a partial sensitization, and at 1/3 hr and earlier no 
sensitization.
Discussion
Morphine, at 5mg/kg and higher doses, showed a signif-
icant ambulatory stimulant effect in mice.  The onset, at-
tainment to the peak, and the duration of the increased am-
bulatory activity were optimum when 10mg/kg of 
morphine was administered.  In addition, naloxone inhibit-
ed the morphine (10mg/kg)-induced ambulatory stimula-
tion in a dose-dependent manner, and 1 mg/kg of naloxone 
was effective for complete inhibition.  According to these 
basic results, 10 mg/kg of morphine and 1 mg/kg of nalox-
one were selected in Experiments 2 and 3.
As demonstrated in Experiment 2, the repeated adminis-
trations of morphine, 6 times at 3-day intervals, induced a 
significant sensitization to the ambulatory stimulant effect, 
Table 3.  Mean activity counts following 3 repeated administrations of morphine (10 mg/kg s.c.) followed 




0  hr  39 ± 7  50 ± 12  44 ± 10
1/6 hr  27 ± 3  31 ± 7  24 ± 9
1/3 hr  53 ± 17  71 ± 26  59 ± 25
1/2 hr  288 ± 64  354 ± 72  453 ± 78*
3/4 hr  558 ± 96  941 ± 126  1335 ± 207*
1  hr  758 ± 141  1158 ± 193  1593 ± 276*
3/2 hr  1228 ± 281  2168 ± 339*  2893 ± 271*
2  hr  1397 ± 310  2574 ± 352*  3379 ± 489*
3  hr  1401 ± 253  2606 ± 392*  3401 ± 420*
Drug administrations were carried out 3 times at 3-day intervals. Each value is mean activity count
±SEM of 10 mice for 3 hr. 
*:  significantly different (p<0.05) vs. the activity count at the 1st administration within each group 
of mice.
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and the effect attained plateau by the 4th administration. 
These results were in agreement with the previous reports 
(Kuribara and Tadokoro, 1989; Kuribara, 1995a).  Even 
though the sensitization to the ambulatory stimulant effect 
was induced by the repeated administration of morphine, 
the time course of changes in the morphine-induced ambu-
latory stimulation was qualitatively the same, and neither 
change in the latency to the peak effect nor prolongation of 
the effect was demonstrated throughout the repeated ad-
ministrations.  These results suggest that the present sched-
ule of repeated morphine administration may not cause 
significant change in the metabolism of morphine, or accu-
mulation of morphine.  In respect to these findings, in Ex-
periment 3, the repeated administrations of morphine were 
carried out 3 times at 3-day intervals, and the challenge 
with morphine was conducted 3 days after the 3rd pretreat-
ment.
In some cases, handling of mice including injection of 
drug or saline acts as stressors, and results in an increased 
sensitivity to morphine (Leyton and Stewart, 1990; Kalivas 
and Stewart, 1991; Deroche et al., 1992; Shaham et al., 
1995).  However, the mice pretreated with saline did not 
show any significant change in sensitivity to challenge-ad-
ministered morphine, suggesting that these treatments did 
not alter neurotransmissions of dopaminergic or opiate 
system which were related to the sensitivity to morphine. 
Naloxone, a prototype of opiate receptor antagonist, in-
hibited the morphine-induced ambulatory sensitization de-
pendent on the treatment schedules.  It is important to note 
that the groups of mice given naloxone during the post-
morphine period of 0-1/3 hr did not show sensitization. On 
the other hand, the mice given naloxone at post-morphine 
period of 1/2 hr demonstrated a partial sensitization, and 
3/4 hr and later a significant sensitization.  These results 
suggest that a repeated experience of the pharmacological 
effect of morphine and resultant ambulatory stimulation 
for at least 1/2 hr during the period of reaching to the peak 
effect, are important to induce sensitization to the ambula-
tion-increasing effect of morphine.  Similar characteristics 
have been observed in the induction of sensitization to the 
ambulatory stimulant effect of methamphetamine (Kuriba-
ra, 1995b, 1996a) and cocaine (Kuribara, 1996a, 2009).  It 
is therefore considered that the mechanisms of sensitiza-
tion to the ambulatory stimulant effect of morphine, meth-
amphetamine and cocaine are basically identical, i.e., stim-
ulation of the mesolimbic dopamine system (Van der 
Heuval and Pasterkamp, 2008; Matsumoto and Hikosaka, 
2009) which is strongly related to the reward effects (Pier-
cem and Kumaresan 2006; Berridge, 2007; Ikemoto, 
2007).
Table 4.  Mean activity counts for 3 hr after the administration of morphine (10 mg/kg s.c.) 
to the mice pretreated with morphine or saline followed by naloxone (1 mg/kg s.c.).
Naloxone at Post-morphine Morphine → Naloxone Saline → Naloxone
0  hr  1390 ± 115  1522 ± 108
1/6 hr  1377 ± 128  1429 ± 131
1/4 hr  1411 ± 103  1497 ± 179
1/2 hr  2507 ± 248*  1401 ± 198
3/4 hr  3205 ± 292*  1501 ± 202
1  hr  3310 ± 313*  1477 ± 129
3/2 hr  3480 ± 322*  1427 ± 141
2  hr  3399 ± 282*  1357 ± 160
3  hr  3417 ± 227*  1387 ± 143
Drug naive  1355 ± 122
Morphine X 3  3490 ± 309*
In the pretreatment, drug administrations were carried out at 3-day intervals, and the 
challenge administration of morphine was conducted 3 days after the 3rd pretreatment.  
Each value is mean activity count±SEM of 10 mice for 3 hr.  
*: significantly different (p<0.05) vs. the activity count of the drug-naïve mice.
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It has been reported that the induction of the behavioral 
sensitization to psychotropic drugs is intimately related to 
the liability of drug abuse (Wise and Bozarth, 1987).  The 
present results also indicate that the early post-morphine 
period prior to the peak effect is intimately related to the 
appearance of the reward effect of morphine, which is es-
sential factor for induction and maintenance of abuse and 
dependence of narcotic analgesic drugs such as morphine 
and heroin.
Conclusion
A significant sensitization to the ambulatory stimulating 
effect of morphine (10 mg/kg s.c.), an opiate receptor ago-
nist, was induced when it was repeatedly administered to 
mice at intervals of 3 days.  The treatment with naloxone 
(1mg/kg s.c.), an opiate receptor blocker, at post-morphine 
period of 1/2 hr partially, and at 0-1/3 hr perfectly inhibited 
the induction of the sensitization to morphine.  However, 
the treatment with naloxone at post-morphine period of 3/4 
hr and later could not block the morphine sensitization. 
These results suggest that the experience of morphine ef-
fect and the resultant ambulation for 1/2 hr prior to the 
peak effect is important for induction of the sensitization 
to the ambulatory stimulant effect of morphine in mice.  It 
is also indicated that the reward effect of morphine appears 
in the early post-morphine period prior to the peak effect, 
which is the essential factor for induction and maintenance 
of the abuse and dependence of narcotic analgesic drugs 
such as morphine and heroin.
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抄録： オピエート受容体アゴニストである麻薬性鎮痛薬モルヒネ（10 mg/kg s.c.）のマウス移所運動促進効果は、3日間隔で
反復投与すると増強し、増感現象が引き起こされた。オピエート受容体アンタゴニストのナロキソン（0.01-1 mg/kg s.c.）
はモルヒネの移所運動促進効果を用量依存的に阻害した。モルヒネ投与から3/4時間以降にナロキソンを投与すると、非
投与群と同程度の増感現象が形成されたが、1/2時間後の投与群では、部分的な増感現象の形成にとどまり、1/3時間以前の
投与群では全く形成されなかった。ナロキソンあるいは生理食塩水の反復投与はモルヒネ感受性に著しい影響を及ぼさな
かった。これらの結果は、マウスの移所運動でみた場合、モルヒネの効果が最大に達するまでの時間帯における1/2時間以
上にわたる運動経験が、増感現象の誘発に重要であることを示している。さらに、モルヒネ乱用・依存の誘発と維持の根源
である報酬的効果は、投与直後に発現することも示唆している。
（別刷請求先：栗原　久）
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